CompletedPhase 1NCT06705192

Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001

Studying Frontotemporal dementia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mads Kjolby
Principal Investigator
Mads Kjoelby, MD, PhD
Vesper Bio
Intervention
VES001(drug)
Enrollment
6 enrolled
Eligibility
18-75 years · All sexes
Timeline
20242025

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06705192 on ClinicalTrials.gov

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

See all trials for Frontotemporal dementia

← Back to all trials